Trials / Completed
CompletedNCT02719951
Glutaminergic Transmission in Autism : Molecular Imaging Exploration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- University Hospital, Tours · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Glutamatergic transmission exploration using PET (Positron Emission Tomography) imaging in autism compared to Fragile-X Syndrome ( FXS) and Healthy Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [18F]FPEB PET imaging | PET exam |
| OTHER | Biological samples | blood sample and urine sample |
| OTHER | MRI | MRI exam |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2018-11-15
- Completion
- 2019-05-01
- First posted
- 2016-03-25
- Last updated
- 2025-12-31
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02719951. Inclusion in this directory is not an endorsement.